The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes

Tropical Medicine and International Health

Volumn 8, Issue 12, 2003, Pages 1082-1092

  Ramaiah, K D ^a   Das, P K ^a   Vanamail, P ^a   Pani, S P ^a  

^a VECTOR CONTROL RESEARCH CENTRE   (India)

Author keywords

Control; Culex quinquefasciatus; Elimination; India; Lymphatic filariasis; Transmission; Wuchereria bancrofti

Indexed keywords

ANTIFILARIAL AGENT; DIETHYLCARBAMAZINE; IVERMECTIN; PLACEBO;

DISEASE CONTROL; DISEASE TRANSMISSION; FILARIASIS; MOSQUITO;

ANIMAL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULEX; CULEX QUINQUEFASCIATUS; DISEASE CARRIER; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG ADMINISTRATION; DRUG EFFECT; ELEPHANTIASIS; FILARIASIS; HEALTH; HUMAN; INDIA; INFECTION RATE; INSECT BITE; ISOLATION AND PURIFICATION; LARVA; LYMPHATIC FILARIASIS; MULTICENTER STUDY; NONHUMAN; PARASITE VECTOR; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; WUCHERERIA BANCROFTI;

ANIMALS; CULEX; DIETHYLCARBAMAZINE; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELEPHANTIASIS, FILARIAL; FILARICIDES; HUMANS; INSECT VECTORS; IVERMECTIN; RURAL HEALTH; WUCHERERIA BANCROFTI;

ANIMALIA; CULEX PIPIENS QUINQUEFASCIATUS; INSECTA; NEMATODA; WUCHERERIA; WUCHERERIA BANCROFTI;

EID: 0348107363     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1360-2276.2003.01138.x     Document Type: Article

References (30)

1. Balakrishnan N, Ramaiah KD & Pani SP (1992) Efficacy of bi-annual administration of DEC in the control of bancroftian filariasis. Journal of Communicable Diseases 24, 87-91.
2. Bockarie MJ, Alexander NDE, Hyun P et al. (1998) Randomised community-based trial of annual single-dose DEC with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet 351, 162-168.
3. Bryan JH & Southgate BA (1976) Some observations on filariasis in Western Samoa after mass administration of diethylcarbamazine. Transactions of the Royal Society of Tropical Medicine and Hygiene 70, 336-341.
4. Cao W, Van Der Ploeg CPB, Plaisier AP, Van Der Sluijs IJ & Habbema JDF (1997) Ivermectin for the chemotherapy of bancroftian filariasis: a meta-analysis of the effect of single treatment. Tropical Medicine and International Health 2, 393-403.
5. Das PK, Ramaiah KD, Augustin DJ & Kumar A (2001a) Towards elimination of lymphatic filariasis in India. Trends in Parasitology 10, 457-460.
6. Das PK, Ramaiah KD, Vanamail P et al. (2001b) Placebo-controlled community trial of four cycles of single-dose diethyl carbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 336-341.
7. Desowitz RS & Southgate BA (1973) Studies on filariasis in the Pacific: 2. The persistence of microfilaraemia in diethylcarbamazine treated populations of Fiji and Western Samoa: diagnostic application of the membrane-filtration technique. Southeast Asian Journal of Tropical Medicine and Public Health 4, 179-183.
8. Gyapong JO (2000) Impact of single-dose ivermectin on community microfilaria load in bancroftian filariasis infection: two years post treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 434-436.
9. Hairston NG & de Meillon B (1968) On the inefficiency of transmission of Wuchereria bancrofti from mosquito to human host. Bulletin of the World Health Organization 38, 935-941.
10. Krishna Rao CH, Sundaram RM, Venkatanarayana M, Sundara Rao J, Chandrasekharan A & Rao CK (1981) Epidemiological studies on bancroftian filariasis in East Godavari district (Andhra Pradesh): entomological aspects. Journal of Communicable Diseases 13, 81-91.
11. McGreevy PB, Kolstrup N, Tao J, McGreevy M & de C Marshall TF (1982) Ingestion and development of Wuchereria bancrofti in Culex quinquefasciatus, Anopheles gambiae and Aedes aegypti after feeding on humans with varying densities of microfilariae in Tanzania. Transactions of Royal Society of Tropical Medicine and Hygiene 76, 288-296.
12. McMahon JE, de C Marshall TF, Vaughan JP & Abaru DE (1979) Bancroftian filariasis: a comparison of microfilaria counting techniques using counting chamber, standard slide and membrane (Nuclepore) filtration. Annals of Tropical Medicine and Parasitology 73, 457-464.
13. Meyrowitsch DW, Simonsen PE & Makunde WH (1996) Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis: comparative efficacy of standard treatment and two semi-annual single dose treatments. Transactions of Royal Society of Tropical Medicine and Hygiene 90, 69-73.
14. Michael E, Bundy DA & Grenfell BT (1996) Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 112, 409-428.
15. Ottesen EA (2000) The global programme to eliminate lymphatic filariasis. Tropical Medicine and International Health 5, 591-594.
16. Ottesen EA, Duke BOL, Karam M & Behbehani K (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of the World Health Organization 75, 491-503.
17. Ottesen EA, Ismail MM & Horton J (1999) The role of albendazole in programmes to eliminate lymphatic filariasis. Parasitology Today 15, 382-386.
18. Ramaiah KD, Das PK & Dhanda V (1994) Estimation of permissible levels of transmission of bancroftian filariasis based on some entomological and parasitological results of a 5-year vector control programme. Acta Tropica 56, 89-96.
19. Ramaiah KD, Das PK, Edwin M & Guyatt H (2000) The economic burden of lymphatic filariasis in India. Parasitology Today 16, 251-253.
20. Ramaiah KD, Vanamail P, Pani SP, Yuvaraj J & Das PK (2002) The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Tropical Medicine and International Health 7, 767-774.
21. Ramaiah KD, Vanamail P, Pani SP & Das PK (2003) The prevalences of Wuchereria bancrofti antigenaemia in communities given six rounds of treatment with diethylcarbamazine, ivermectin or placebo tablets. Annals of Tropical Medicine and Parasitology (in press).
22. Southgate BA (1984) Recent advances in the epidemiology and control of filarial infections including entomological aspects of transmission. Transactions of the Royal Society of Tropical Medicine and Hygiene 78(Suppl), 19-28.
23. Southgate BA (1992) The significance of low density microfilaraemia in the transmission of lymphatic filariasis. Journal of Tropical Medicine and Hygiene 95, 79-86.
24. Southgate BA & Bryan JH (1992) Factors affecting transmission of Wuchereria bancrofti by anopheline mosquitoes. 4. Facilitation, limitation proportionality and their epidemiological significance. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 523-530.
25. Subra R (1980) Biology and control of Culex pipiens quinque-fasciatus Say, 1823 (Diptera, Culicidae) with special reference to Africa. WHO/VBC/80.781
26. Subramanian S, Krishnamoorthy K, Ramaiah KD, Habbema JDF, Das PK & Plaisier AP (1998) The relationship between microfilarial load in the human host and uptake and development of Wuchereria bancrofti microfilariae by Culex quinque-fasciatus: a study under natural conditions. Parasitology 116, 243-255.
27. Vanamail P, Ramaiah KD, Pani SP, Das PK, Grenfell BT & Bundy DA (1996) Estimation of the fecundic life span of Wuchereria bancrofti in an endemic area. Transactions of the Royal Society of Tropical Medicine and Hygiene 90, 119-121.
28. Webber RH (1991) Can anopheline-transmitted filariasis be eradicated? Journal of Tropical Medicine and Hygiene 94, 241-244.
29. WHO (1977) The biomedical criteria for resettlement in the Volta Basin Onchocerciasis Control Programme (OCP) area. Report of a Scientific Advisory Panel Working Group. (Mimeograph OCP/SAP/77.1) World Health Organization, Geneva.
30. WHO (1995) World Health Report 1995: Bridging the Gaps. WHO, Geneva, p. 118.